Microalbuminuria and clinical correlates in black African patients with type 2 diabetes

West African Journal of Medicine

Volumn 25, Issue 4, 2006, Pages 279-283

  Adetunji, O R ^a   Adeleye, J O ^a   Agada, N O ^a   Salako, B L ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOASSAY; LIPOPROTEIN BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; MICROALBUMINURIA; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREVALENCE; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; TURBIDIMETRY; URINALYSIS; URINARY EXCRETION;

ALBUMINURIA; BLOOD GLUCOSE; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; LINEAR MODELS; LIPOPROTEINS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 33847624193     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ayodele O E, Alebiosu C O, Salako B L. Diabetic nephropathy a review of the natural history, burden, risk factors and treatment. J. Natl Med. Assoc. 2004; 96: 1215-8.
2. Prevention of D M. Report of WHO study group technical report series 844. Geneva: WHO study group, 1994.
3. Rabkin R. Diabetic nephropathy. Clin cornerstone 2003; 5: 1-11.
4. USRDS Annual Data Report: Atlas of end stage renal disease in the United States. National Institute of Health, National Institute of diabetes and digestive and kidney diseases, Bethseda, M D: U S. Renal data system, 2002.
5. Alebiosu C. Clinical diabetic nephropathy in a tropical African population. West Afr Med. 2003; 22: 152-5..
6. Viberti G C, Hill R D, Jrrett R J, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nepbropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1: 1430-2.
7. Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 2002; 25: 28S-32.
8. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-17.
9. Alzaid A. Microalbuminuria in patients with NIDDM: an overview. Diabetes Care 1996; 19: 79-89.
10. Standards of Medical Care for Patients With Diabetes Mellitus. Diabetes Care 2003; 26: 33S-50.
11. Nephropathy in Diabetes. ADA Position Statement. Diabetes Care 2004; 27: S79-S83.
12. Adebisi S A, Okesina A B, Abu E O. Microalbuminuria in type 2 diabetic patients in Ilorin, Nigeria. Diabetes International 2001; 11: 93-95.
13. Agaba E I A P, Puepet F H. Prevalence of microalbuminuria in newly diagnosed type 2 diabetic patients in Jos Nigeria. Afr J Med med Sci. 2004; 33: 19-22.
14. Erasmus R, Oyeyinka G, Arije A. Microalbuminuria in non-insulin-dependent (type 2) Nigerian diabetics: relation to glycaemic control, blood pressure and retinopathy. Postgrad. Med. J. 1992; 68: 638-642.
15. Maiza A T A, Malek R et al. Prevalence of microalbuminuria in Algerian diabetic patients. International Diabetes Digest 1997; 7: 31.
16. Niskanen L K, Penttila I, Parviainen M, Uusitupa M I. Evolution, risk factors, and prognostic implications of albuminuria in NIDDM. Diabetes Care 1996; 19: 486-93.
17. Gall M A, Hougaard P, Borch-Johnsen K, Parving H H. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 1997; 314: 783-8.
18. Bruno G, Merletti F, Biggeri A, et al. Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 2003; 26: 2150-5.
19. Konen J C, Summerson J H, Bell R A. Abnormal urinary protein excretion in African Americans with type 2 diabetes mellitus. Ethn Dis 1999; 9: 3-9.
20. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-86.
21. Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med 2002; 346: 1145-51.
22. Gall M A, Rossing P, Skott P, et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655-61.
23. Gerstein H C, Mann J F, Pogue J, et al. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators. Diabetes Care 2000; 23 Suppl 2: B35-9.
24. Mogensen C E, Schmitz O. The diabetic kidney: from hyperfiltration and microalbuminuria to end-stage renal failure. Med Clin North Am 1988; 72: 1465-92.